Azafaros is developing new treatment options to help patients with rare metabolic disorders. Azafaros was founded in 2018 by a team of experienced industry professionals and scientists aspiring to address rare genetic metabolic disorders through a pipeline of oral small molecules with disease-modifying potential. 

Biotechnology

Azafaros

Azafaros' headquarters in Naarden, Netherlands

Stefano Portolano

Henrik Torp Nielsen

Silvia Ragno

Christian Freitag

Carlo Incerti

Vanessa King

Edward Van Wezel

Sander Slootweg

Kiran Dallenbach

Description

People (1)

Edward Van Wezel

Jobs